Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2002 | 09-2001 | 09-2000 | 09-1999 | 09-1998 | |
| Sales | 59,104 | 56,527 | 57,096 | 53,927 | 33,160 |
| Cost of Goods | 24,506 | 29,821 | 21,650 | 19,558 | 10,650 |
| Gross Profit | 34,598 | 26,706 | 35,446 | 34,369 | 22,510 |
| Operating Expenses | 25,110 | 40,034 | 26,742 | 28,400 | 14,810 |
| Operating Income | 9,994 | -12,507 | 9,354 | 6,527 | 8,350 |
| Interest Expense | 1,974 | 2,546 | 2,124 | 2,143 | 1,620 |
| Other Income | 223 | 147 | -292 | 428 | 1,320 |
| Pre-tax Income | 8,243 | -14,906 | 6,938 | 4,812 | 8,050 |
| Income Tax | 3,212 | -4,631 | -173 | 2,739 | 3,090 |
| Net Income Continuous | 5,031 | -10,275 | 7,111 | 2,073 | 4,958 |
| Net Income | $5,031 | $-10,275 | $7,111 | $2,073 | $4,950 |
| EPS Basic Total Ops | 0.15 | -0.31 | 0.22 | 0.06 | 0.15 |
| EPS Basic Continuous Ops | 0.15 | -0.31 | 0.22 | 0.06 | 0.15 |
| EPS Diluted Total Ops | 0.15 | -0.31 | 0.22 | 0.06 | 0.15 |
| EPS Diluted Continuous Ops | 0.15 | -0.31 | 0.22 | 0.06 | 0.15 |
| EBITDA(a) | $13,713 | $-7,761 | $14,165 | $12,200 | $11,230 |